5 days ago
BMRN
AnalystsEliana MerleEliana Merle's Stock Forecasts
AnalystsEliana Merle
Sectors:
Industries:
Analyst Ranking
Top 11%
#580 out of 5497 analysts
Average Return
+13.35%
Win Rate
58%68 out of 117
Risk vs Reward
Poor
Good
Eliana Merle's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Iveric Bio IncISEE | +237.97% | $11.01 | $37.21 | 2022-08-02 - 2023-05-03 | Strong Buy |
Cymabay Therapeutics IncCBAY | +213.84% | $1.59 | $4.99 | 2020-03-13 - 2021-03-12 | Strong Buy |
Kymera Therapeutics IncKYMR | +168.30% | $31.14 | $83.55 | 2025-05-13 - 2026-05-12 | Strong Buy |
Cymabay Therapeutics IncCBAY | +166.61% | $12.07 | $32.18 | 2023-08-14 - 2024-02-14 | Strong Buy |
Kadmon Holdings IncKDMN | +148.04% | $3.83 | $9.50 | 2021-05-21 - 2021-11-09 | Strong Buy |
Eliana Merle Analyst Color
Get additional color on Eliana Merle's coverage of popular stocks
8 days ago
PTCT
17 days ago
VRTX
3 months ago
MBX
3 months ago
ASND
5 months ago
INSM
5 months ago
IONS
6 months ago
BMRN
7 months ago
KYMR
7 months ago
VRTX
7 months ago
PTCT
a year ago
BBIO
a year ago
GOSS
a year ago
ALNY
a year ago
PROK
2 years ago
BMRN
2 years ago
ETNB
2 years ago
AKRO
2 years ago
RVMD
2 years ago
BMRN
2 years ago
MRNA
2 years ago
APLS
3 years ago
CBAY
3 years ago
APLS
5 years ago
MRNA
Eliana Merle's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Biomarin Pharmaceutical IncBMRN | 5 | Strong Buy | $111.00 | +66.42% | Maintains | 5 days ago |
Ptc Therapeutics IncPTCT | 2 | Strong Buy | $122.00 | +74.74% | Maintains | 8 days ago |
Ascendis Pharma AASND | 5 | Strong Buy | $329.00 | +29.89% | Maintains | 8 days ago |
Regenxbio IncRGNX | 2 | Hold | $12.00 | +11.94% | Downgrades | 15 days ago |
Kymera Therapeutics IncKYMR | 5 | Strong Buy | $139.00 | +16.03% | Maintains | 16 days ago |
Vertex Pharmaceuticals IncVRTX | 4 | Strong Buy | $617.00 | +12.58% | Maintains | 17 days ago |
Madrigal Pharmaceuticals IncMDGL | 7 | Strong Buy | $962.00 | +86.17% | Maintains | 19 days ago |
Alnylam Pharmaceuticals IncALNY | 5 | Strong Buy | $450.00 | +90.50% | Maintains | 19 days ago |
Uniqure NvQURE | 8 | Strong Buy | $60.00 | +24.04% | Maintains | 23 days ago |
Ionis Pharmaceuticals IncIONS | 3 | Strong Buy | $90.00 | +50.65% | Maintains | a month ago |
Sab Biotherapeutics IncSABS | 1 | Strong Buy | $13.00 | +243.92% | Initiates Coverage On | 2 months ago |
Gossamer Bio IncGOSS | 6 | Strong Sell | $0.28 | +80.65% | Maintains | 3 months ago |
Mbx Biosciences IncMBX | 2 | Strong Buy | $70.00 | +5.53% | Maintains | 3 months ago |
Moderna IncMRNA | 11 | Hold | $45.00 | -68.99% | Maintains | 4 months ago |
Regeneron Pharmaceuticals IncREGN | 2 | Strong Buy | $917.00 | +9.95% | Maintains | 4 months ago |
Ultragenyx Pharmaceutical IncRARE | 1 | Strong Buy | $43.00 | +66.47% | Maintains | 4 months ago |
Insmed IncINSM | 2 | Strong Buy | $237.00 | +88.44% | Maintains | 5 months ago |
Apellis Pharmaceuticals IncAPLS | 9 | Hold | $41.00 | -0.07% | Maintains | 5 months ago |
Tpg IncTPG | 2 | Strong Buy | $56.00 | +6.87% | Maintains | 6 months ago |
Tyra Biosciences IncTYRA | 2 | Strong Buy | $59.00 | +126.49% | Initiates Coverage On | 7 months ago |
Sagimet Biosciences IncSGMT | 2 | Hold | $8.00 | -21.95% | Initiates Coverage On | 7 months ago |
Inventiva SaIVA | 2 | Strong Buy | $18.00 | +284.62% | Initiates Coverage On | 7 months ago |
4d Molecular Therapeutics IncFDMT | 1 | Strong Buy | $33.00 | +108.46% | Initiates Coverage On | 7 months ago |
Bridgebio Pharma IncBBIO | 5 | Strong Buy | $80.00 | -1.84% | Initiates Coverage On | 7 months ago |
Altimmune IncALT | 2 | Strong Buy | $24.00 | N/A | Maintains | a year ago |
Rapt Therapeutics IncRAPT | 4 | Hold | $9.00 | N/A | Maintains | a year ago |
Anaptysbio IncANAB | 5 | Hold | $20.00 | N/A | Maintains | a year ago |
Sarepta Therapeutics IncSRPT | 1 | Hold | $12.00 | N/A | Downgrades | a year ago |
Prokidney CorpPROK | 1 | Strong Buy | $8.00 | N/A | Maintains | a year ago |
Curevac NvCVAC | 3 | Hold | $5.50 | N/A | Downgrades | a year ago |
Arvinas IncARVN | 5 | Strong Buy | $21.00 | N/A | Maintains | a year ago |
89bio IncETNB | 3 | Strong Buy | $38.00 | N/A | Maintains | 2 years ago |
Akero Therapeutics IncAKRO | 4 | Strong Buy | $109.00 | N/A | Maintains | 2 years ago |
Zentalis Pharmaceuticals IncZNTL | 4 | Hold | $2.20 | N/A | Maintains | 2 years ago |
Revolution Medicines IncRVMD | 2 | Strong Buy | $71.00 | N/A | Maintains | 2 years ago |
Biontech SeBNTX | 4 | Hold | $131.00 | N/A | Maintains | 2 years ago |
Kodiak Sciences IncKOD | 3 | Hold | $5.00 | N/A | Maintains | 2 years ago |
Terns Pharmaceuticals IncTERN | 2 | Strong Buy | $18.00 | N/A | Maintains | 2 years ago |
Cymabay Therapeutics IncCBAY | 5 | Hold | $32.50 | N/A | Downgrades | 3 years ago |
Iveric Bio IncISEE | 2 | Hold | $40.00 | N/A | Downgrades | 3 years ago |
Monte Rosa Therapeutics IncGLUE | 1 | Strong Buy | $22.00 | N/A | Initiates Coverage On | 4 years ago |
Kadmon Holdings IncKDMN | 1 | Strong Buy | $9.00 | N/A | Initiates Coverage On | 5 years ago |
Amicus Therapeutics IncFOLD | 2 | Strong Buy | $16.00 | N/A | Initiates Coverage On | 5 years ago |
Lakefront Biotherapeutics NvLKFT | 2 | Hold | $134.00 | N/A | Maintains | 6 years ago |
Alexion Pharmaceuticals IncALXN | 1 | Hold | $121.00 | N/A | Initiates Coverage On | 6 years ago |
Cartesian Therapeutics IncRNAC | 1 | Strong Buy | $10.00 | N/A | Initiates Coverage On | 7 years ago |
Tesaro IncTSRO | 1 | Strong Buy | $68.00 | N/A | Maintains | 8 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.